Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: PKCepsilon plays a causal role in acute ethanol-induced steatosis.

Authors: Kaiser, J Phillip; Beier, Juliane I; Zhang, Jun; David Hoetker, J; von Montfort, Claudia; Guo, Luping; Zheng, Yuting; Monia, Brett P; Bhatnagar, Aruni; Arteel, Gavin E

Published In Arch Biochem Biophys, (2009 Feb)

Abstract: Steatosis is a critical stage in the pathology of alcoholic liver disease (ALD), and preventing steatosis could protect against later stages of ALD. PKCepsilon has been shown to contribute to hepatic steatosis in experimental non-alcoholic fatty liver disease (NAFLD); however, the role of PKCepsilon in ethanol-induced steatosis has not been determined. The purpose of this study was to therefore test the hypothesis that PKCepsilon contributes to ethanol-induced steatosis. Accordingly, the effect of acute ethanol on indices of hepatic steatosis and insulin signaling were determined in PKCepsilon knockout mice and in wild-type mice that received an anti-sense oligonucleotide (ASO) to knockdown PKCepsilon expression. Acute ethanol (6g/kg i.g.) caused a robust increase in hepatic non-esterified free fatty acids (NEFA), which peaked 1h after ethanol exposure. This increase in NEFA was followed by elevated diacylglycerols (DAG), as well as by the concomitant activation of PKCepsilon. Acute ethanol also changed the expression of insulin-responsive genes (i.e. increased G6Pase, downregulated GK), in a pattern indicative of impaired insulin signaling. Acute ethanol exposure subsequently caused a robust increase in hepatic triglycerides. The accumulation of triglycerides caused by ethanol was blunted in ASO-treated or in PKCepsilon(-/-) mice. Taken together, these data suggest that the increase in NEFA caused by hepatic ethanol metabolism leads to an increase in DAG production via the triacylglycerol pathway. DAG then subsequently activates PKCepsilon, which then exacerbates hepatic lipid accumulation by inducing insulin resistance. These data also suggest that PKCepsilon plays a causal role in at least the early phases of ethanol-induced liver injury.

PubMed ID: 19022218 Exiting the NIEHS site

MeSH Terms: Actins/genetics; Animals; DNA Primers; Ethanol/toxicity*; Fatty Liver/chemically induced*; Fatty Liver/enzymology; Glucokinase/genetics; Liver Diseases, Alcoholic/enzymology*; Liver Diseases, Alcoholic/pathology; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotides, Antisense; Protein Kinase C-epsilon/deficiency; Protein Kinase C-epsilon/genetics; Protein Kinase C-epsilon/metabolism*; RNA, Messenger/genetics; RNA, Messenger/isolation & purification; Reverse Transcriptase Polymerase Chain Reaction; Triglycerides/metabolism

Back
to Top